JOURNAL BACTERIOLOGY, Jan. 2004, p. 473â€“480                                                                                Vol. 186,  2
0021-9193/04/$08.00â«¹0 DOI: 10.1128/JB.186.2.473â€“480.2004
Copyright Â© 2004, American Society Microbiology. Rights Reserved.



 Sorbitol Phosphotransferase Responsible Transport
         2-C-Methyl-D-Erythritol Salmonella enterica
                       Serovar Typhimurium
                              Charles  Testa,â€  Rita M. Cornish, C. Dale Poulter*
                               Department Chemistry, University Utah, Salt Lake City, Utah 84112
                                              Received 23 June 2003/Accepted 8 October 2003

            2-C-methyl-D-erythritol 4-phosphate committed intermediate biosynthesis isoprenoid
          precursors isopentenyl diphosphate dimethylallyl diphosphate. Supplementation growth medium
          2-C-methyl-D-erythritol shown complement disruptions Escherichia coli gene           1-deoxy-D-xylulose 5-phosphate synthase, enzyme synthesizes immediate precursor 2-C-methyl-
          D-erythritol 4-phosphate. order utilized isoprenoid biosynthesis, 2-C-methyl-D-erythritol           phosphorylated. construction Salmonella enterica serovar Typhimurium strain RMC26,           essential gene encoding 1-deoxy-D-xylulose 5-phosphate synthase disrupted insertion           synthetic mevalonate operon consisting yeast ERG8, ERG12, ERG19 genes, responsible           converting mevalonate isopentenyl diphosphate control arabinose-inducible promoter.
          Random mutagenesis RMC26 produced defects sorbitol phosphotransferase prevented
          transport 2-C-methyl-D-erythritol cell. RMC26 mutant strains RMC26 unable grow           2-C-methyl-D-erythritol incubated buffer containing mevalonate deuterium-labeled 2-C-methyl-D-
          erythritol. Ubiquinone-8 isolated cells analyzed deuterium content. Efficient incorpo-
          ration deuterium observed RMC26.  evidence deuterium incorporation           isoprenoid chain ubiquinone Q8 RMC26 mutants.


   33,000 different compounds known date,                  D-glyceraldehyde 3-phosphate pyruvate 1-deoxy-
isoprenoids diverse groups compounds                   D-xylulose 5-phosphate (DXP) (30). MEP synthase cata- nature (9). Isoprenoid molecules important                lyzes NADPH-dependent rearrangement reduction
wide variety cellular functions, including electron transport             DXP MEP (27). DXP precursor bio-
(quinones), stabilization membranes (sterols), cell wall bio-             synthesis vitamins B1 B6.  MEP com-
synthesis (dolichols), signaling (prenylated proteins hor-               mitted precursor biosynthesis IPP DMAPP. MEP
mones), photosynthesis (chlorophylls), photoprotection (caro-                converted 2-C-methyl-D-erythritol 2,4-cyclodiphosphate
tenoids), protein synthesis (modified tRNAs). Despite                  (cMEPP) consecutive actions 4-diphosphocytidyl-2-
high degree structural diversity, isoprenoids derived             C-methyl-D-erythritol synthase, 4-diphosphocytidyl-2-C-meth- simple carbon molecules, isopentenyl diphos-                   yl-D-erythritol 2-phosphate synthase, cMEPP synthase (22,
phate (IPP) dimethylallyl diphosphate (DMAPP). Al-                       28, 29, 31, 39). reductive ring-opening cMEPP produces higher isoprenoid molecules derived IPP                  1-hydroxy-2-methyl-2-buten-4-yl diphosphate (4, 11, 21). DMAPP, fundamental building blocks produced                    final step, protein encoded ispH  lytB) converts different biosynthetic pathways.                                      1-hydroxy-2-methyl-2-buten-4-yl diphosphate mixture    Archaea, Eukarya, gram-positive bacteria, IPP                 IPP DMAPP (2, 3, 13, 32, 38). segregation DMAPP synthesized acetyl coenzyme                      MVA MEP pathways makes attractive target
mevalonate (MVA) pathway (Fig. 1). steps                development antibiotics herbicides.
MVA pathway condense molecules acetyl coenzyme                       Disruptions genes encoding proteins form 3-hydroxy-3-methylglutaryl-coenzyme (HMG-CoA)                      MEP pathway lethal (3, 4, 10, 11, 13, 20, 32). Disruptions
(24, 33). HMG-CoA reduced MVA,                       dxs complemented supplementation growth
verted MVA diphosphate steps (5, 8). IPP obtained                  medium deoxyxylulose (DX) 2-C-methyl-D-erythritol ATP-dependent decarboxylation MVA diphosphate                     , disruptions dxr complemented isomerized DMAPP (1, 15). 2-C-methyl-D-eryth-                    (6, 16, 19, 37, 40, 43). order utilized MEP
ritol 4-phosphate (MEP) pathway orthogonal MVA                     pathway, exogenous DX transported pathway (Fig. 1) bacteria plant chlo-               cell phosphorylated. DX converted DXP D-xylu-
roplasts. step MEP pathway condensation              lokinase, enzyme normally phosphorylates D-xylulose
                                                                             (46), point transport mechanism uptake
                                                                             DX known. Likewise, mechanism uptake    * Corresponding author. Mailing address: Department Chemis-            established.
try, University Utah, Salt Lake City, UT 84112. Phone: (801) 581-
6685. Fax: (801) 581-4391. E-mail: poulter@chem.utah.edu.
                                                                                Work laboratory (20) Boronat col-
   â€  Present address: Echelon Biosciences, , Salt Lake City, UT          leagues (10) demonstrated ability plasmid-encoded
84108.                                                                       MVA operon restore cell viability strains Escherichia

                                                                       473
 474      TESTA ET AL.                                                                                                                               J. BACTERIOL.

                                                                                   1 M MVA lactone 1.02 volumes 1 M KOH followed incubation                                                                                    mixture 37Â°C 30 min. DX prepared previously described (7)                                                                                    used concentration 2 mM. L-arabinose (Ara) used concentration
                                                                                   0.02 .
                                                                                      General methods. Minipreparations plasmid DNA restriction analysis
                                                                                   using QIAprep Spin Miniprep kits (Qiagen). Large-scale plasmid
                                                                                   preparations using Qiagen Plasmid Midi Prep kits. PCR products
                                                                                   purified QIAquick PCR purification kits (Qiagen) agarose gels
                                                                                   (GIBCO) soaking band overnight TE purification using
                                                                                   QIAquick gel extraction kits (Qiagen). Genomic DNA isolated using Easy
                                                                                   DNA kits (Invitrogen). Restriction digests, ligations, transformations, elec-
                                                                                   troporations performed described Sambrook et al. (41). PCRs                                                                                    carried using Perkin-Elmer GeneAmp PCR 2400 DNA thermal
                                                                                   cycler KlenTaq LA polymerase mix (Clontech), unless noted.
                                                                                   Chain reaction cloning (CRC) performed described Pachuk et al. (34).
                                                                                   E. coli DH5â?£ (GIBCO) used host plasmid constructs. S. enterica
                                                                                   serovar Typhimurium strain TR6579 used shuttle plasmids constructed                                                                                    E. coli S. enterica serovar Typhimurium. Transductions mediated                                                                                    high-frequency P22 mutant HT105/1 int-201 previously described (42). Phage
                                                                                   P22 lysates prepared previously described (14). Random mutagenesis
                                                                                   performed described Hughes Roth (23) using TE3461 (17)                                                                                    Mud-Cam insertions selecting LB-CAM-MVA-Ara LB-CAM. â?­-Red-
                                                                                   mediated recombination performed described Price-Carter et al. (36).
                                                                                   DNA sequenced Health Sciences Center Sequencing Facility, Eccles
                                                                                   Institute Human Genetics, University Utah. Sequence searches 
                                                                                   formed National Center Biotechnology Information WU GSC
                                                                                   BLAST server, Genome Sequencing Center, Washington University School                                                                                    Medicine.
             FIG. 1. MVA (left) MEP (right) pathways.                             Plasmid strain construction. Plasmids bacterial strains used                                                                                    study listed Table 2. parental S. enterica serovar Typhimurium strains
                                                                                   phages used gifts J. Roth (University Californiaâ€”Davis).
                                                                                      Construction pCAT53-3. SalI fragment pUC4K containing coli disrupted dxs. bacterium blocked                     gene conferring Kanr ligated XhoI site pFCO1 (20) form novo biosynthesis IPP DMAPP MEP                                pFCO1/kan. Transformants bearing ligated products selected LB-
pathway able synthesize molecules MVA.                        KAN. PBAD promoter araC gene excised pBAD/gIII  
                                                                                   vitrogen) digestion NsiI, treatment Klenow blunt end, diges- identify genes involved MEP pathway, chromo-                         tion SacI, followed ligation resulting fragment pFCO1/kan,
somal copy dxs Salmonella enterica serovar Typhimurium                       digested SapI, treated Klenow, digested disrupted synthetic MVA operon (20).                          SacI form pCAT53-3.
chromosomal disruption, araBAD promoter pBAD                                 Construction pRMC14. S. enterica serovar Typhimurium dxs PCR
                                                                                   amplified genomic template, ligated directly pGEM-T (Promega), inserted upstream MVA pathway genes                                                                                    digested Bsu36I EcoRV subsequently treated Klenow kanamycin resistance (Kanr) cassette appended downstream                        4-kb fragment. 7-kb Klenow-treated BsrBI/PspOMI fragment allow easy detection insertion mutants. facilitate cor-                    pCAT53-3 ligated 4-kb fragment pRMC13 create pRMC14
rect insertion, MVA operon flanked regions                           using CRC. bridge oligonucleotides crcDXSARA crcKANDXS homology dxs. Boronat colleagues (10) described                        used thermal cycler settings denaturation 94Â°C 30 s, followed                                                                                    annealing cycle 52Â°C 30 s ligation 66Â°C 1 min 30 cycles. related construct synthetic MVA operon                             Construction RMC26. â¬ƒ8-kb BsrBI/SpeI fragment pRMC14 inserted tryptophan biosynthetic operon E. coli                    electroporated TT22236 containing â?­-Red plasmid pTP223 (35). Linear
chromosomal dxs disrupted chloramphenicol acetyl-                       recombinants selected plating LB-KAN  correct insertion
transferase (CAT) cassette. report work impli-                         initially verified phenotypically growth LB-KAN LB-KAN-
                                                                                   MVA-Ara lack growth LB-KAN. Subsequent verification cates sorbitol phosphotransferase (PTS)                                                                                    accomplished PCR using primers nested ispA (sISPA1) araC
transport phosphorylation  review PTS,                      (asARAC1) end insertion primers nested yajO (asYAJO1)
reference 45).                                                                     Kan cassette (sKAN1) end insert followed                                                                                    sequencing PCR products. genes ispA yajO flank dxs. strain
                                                                                   designated RMC25. insertion backcrossed LT2 result                        MATERIALS METHODS
                                                                                   RMC26, disruption designated dxs::MVAoperon.
   Materials. Restriction endonucleases, Klenow fragment, T7 DNA poly-            Random mutagenesis RMC26. Mutagenesis experiments conducted
merase purchased New England Biolabs. Ampicillin, kanamycin              using TE3461 donor strain standard P22 transduction RMC26 (KAN), chloramphenicol (CAM) purchased Sigma. Shrimp al-             recipient, resulting random Mud-Cam insertions (17, 23). Mutants kaline phosphatase purchased U.S. Biochemical Corp. Ampligase         selected plating transduction crosses directly LB-CAM-MVA-Ara. purchased Epicentre Technologies Corporation. KlenTaq-LA DNA poly-            incubation 2 days 37Â°C, plates replica printed LB-CAM merase mix purchased Clontech. Taq/TaqStart DNA polymerase, E.            LB-CAM-MVA-Ara. Colonies exhibiting growth MVA-Ara coli DH5â?£ competent cells, agarose purchased GIBCO. Oligo-           streaked green-CAM-MVA-Ara plates. Nonlysogenic colonies
nucleotides used study listed Table 1 custom synthesized   (white colonies green plates) cross streaked P22 (H5) ensure Protein/DNA Core Facility Utah Regional Cancer Center.               phage sensitivity. phage-sensitive mutants verified, single colonies
   Growth media supplements. Luria-Bertani (LB) used       streaked LB-CAM-MVA-Ara plates. cells grew, plates
supplementation growth conditions (41). KAN used concentra-       replica plated described previously. Cells exhibiting proper pheno-
tion 40 â?®g/ml, CAM used concentration 20 â?®g/ml, ampicillin      type used inoculate liquid cultures, insertion point Cam used concentration 100 â?®g/ml. [1,1-2H2]2-C-methyl-D-eryth-      cassette determined single-primer (semirandom) PCR genomic
ritol ([1,1-2H2  synthesized described Duvold et al. (16) used   DNA. Semirandom PCR (23) performed using Taq/TaqStart prim- concentration 50 â?®g/ml. MVA prepared hydrolysis 1 volume      ers smud33, smud54, smud59, smud86. Thermal cycler settings  475
METHYL ERYTHRITOL TRANSPORT SEROVAR TYPHIMURIUM




                                                                                                         TABLE 1. Oligonucleotide sequences used study
                                                     Oligonucleotide                                                                   Sequencea
                                                     crcDXSARA            5â¬˜   CAATGAATCACGCAGGCGATCTCGCCGCAGCCGAACGACC 3â¬˜
                                                     crcKANDXS            5â¬˜   TGCAGGTCGAGGGGGGGCCTGAGGGGCGAAAGTCGTAAA 3â¬˜
                                                     sISPA1               5â¬˜   CGTTAGACTTGGGCGTTGAG 3â¬˜
                                                     asARAC1              5â¬˜   CTTTTGAGCACCACCCGGAT 3â¬˜
                                                     asYAJO1              5â¬˜   AGTTAATGCCGCCCTCAAGG 3â¬˜
                                                     sKAN1                5â¬˜   GGCAGAGCATTACGCTGACT 3â¬˜
                                                     SygbPFRT2            5â¬˜   GGGCAAACTCATCGATAAACCATCCAGGGATTTAACATGGCAGCCACTTTATTGGACGTTTGCGCCGTGGTGCCGGCGAAGCCACTGGAGCACCTCAA
                                                                          3â¬˜
                                                     ASygbPFRT2           5â¬˜   CCAAACGCGTGTACGTCAAAACCGTGTCCAATTCGCATTATGCTTTCTCCTGGTGGATGGTTCGGGTCAGATAAACGGGGAGAGCCTGAGCAAA 3â¬˜
                                                     sychBcamPCR          5â¬˜   ATGATGACCCATTGGCCTTCTCCGGCAAAATTAAATCTGTTTTTATATATCACCGGACGAAGCCACTGGAGCACCTCAA 3â¬˜
                                                     asychBcamPCR         5â¬˜   TTAGAGTAACTCTCGATGCAATGGGGAGAGGTTGACACCCTTCGCCACAAAAGCATTGAGCGGGGAGAGCCTGAGCAAA 3â¬˜
                                                     sychBCamseq2         5â¬˜   GGTGGCTATGACAGCAAAA 3â¬˜
                                                     asychBCamseq2        5â¬˜   GGATCCTTACTCGTCTTCATTCAC 3â¬˜
                                                     sygbBcamPCR          5â¬˜   ATGCGAATTGGACACGGTTTTGACGTACACGCGTTTGGCGGAGAAGGGCCGATTATTATTAAGCCACTGGAGCACCTCAA 3â¬˜
                                                     asygbBcamPCR         5â¬˜   TCATTTCGCCGCCTTCATCAGCAACGCGACCGCTTCGCAGGCAATGCCTTCTCCGCGTCCCGGGGAGAGCCTGAGCAAA 3â¬˜
                                                     sygbBCamseq2         5â¬˜   TAAATCTTCAACCACCACAAAATCTTCC 3â¬˜
                                                     asygbBCamseq2        5â¬˜   GGATCCAATTTTATCTGACCCGAA 3â¬˜
                                                     sgcpEcam2            5â¬˜   TTATTTTTCAACCTGCAGCACGTCAATCCGACGCGCTTCAAGCCACTGGAGCACCTCAA 3â¬˜
                                                     asgcpEcam2           5â¬˜   ATGCATAACCAGGCTCCGATTCAACGTAGAAAATCGACACGGGGAGAGCCTGAGCAAA 3â¬˜
                                                     sgcpEseq             5â¬˜   CCAGGCAGATAATCGTTCATG 3â¬˜
                                                     sgcpEseq             5â¬˜   GTATCAAGGAAAACCTGTCG 3â¬˜
                                                     smud33               5â¬˜   ACCTTTGGTCACCAACGCTTTTCC 3â¬˜
                                                     smud54               5â¬˜   CCGAATAATCCAATGTCC 3â¬˜
                                                     smud59               5â¬˜   CAGATCCCGAATAATCCAATGTCCT 3â¬˜
                                                     smud86               5â¬˜   GCAAGCCCCACCAAATCTAATCCCA 3â¬˜
                                                     sgutEFRT2            5â¬˜   ACTTGAGCAGAAAGTTCATCTGACAGGAGCGGTATCATGACACGGGTTCGCATTGAGAAAGGCGCCGGCGGCTGGGGCAAGCCACTGGAGCACCTCAA
                                                                          3â¬˜
                                                     asgutEFRT2           5â¬˜   ATGGTGGTTTGATAAATCACGCTCATGTCTGAACCTCTTATTGATAGATAAAGCCGGAAACAAACCAGGCGATAAGTACGGGGAGAGCCTGAGCAAA 3â¬˜
                                                     SgutEseq             5â¬˜   CATATGTCACCGATCTCACCACCGCT 3â¬˜
                                                     ASgutEseq            5â¬˜   GGATCCGCTCATGTCTGAACCTCTTA 3â¬˜
                                                     Ssr1E                5â¬˜   CCATGGCACGGGTTCGCATTGAGAAAGGC 3â¬˜
                                                     STYasgutEPCR         5â¬˜   CGGATTCTTAATGATGATGATGATGATGTTGATAGATAAAGCCGGAAA CAAACC 3â¬˜
                                                     SsrlACam             5â¬˜   AGAAAACTAAAAACCCTACAGGAGAGAACAATGATCGAAAAAGCCACTGGAGCACCTCAA 3â¬˜
                                                     ASsrlACam            5â¬˜   CAATGCGAACCCGTGTCATGATACCGCTCCTGTCAGATGACGGGGAGAGCCTGAGCAAA 3â¬˜
                                                     SsrlBCam             5â¬˜   GGCTTTATCTATCAATAAGAGGTTCAGACATGAGCGTGATAAGCCACTGGAGCACCTCAA 3â¬˜
                                                     ASsrlBCam            5â¬˜   CAACGGCAACTTGATTCATGTTTTTTCTCCTTAAGCGACACGGGGAGAGCCTGAGCAAA 3â¬˜
                                                     SsrlAX               5â¬˜   TTGCGATCACAATAACACT 3â¬˜
                                                     ASsrlAX              5â¬˜   TGTTAGTTGCGCCAGTTT 3â¬˜
                                                     SsrlBX               5â¬˜   CAGATGCTGATTACGTTTCG 3â¬˜
                                                     ASsrlBX              5â¬˜   GATTAAAGCGGGAAATCTGC 3â¬˜
                                                                                                                Italics indicate homology CAT.
VOL. 186, 2004
 476       TESTA ET AL.                                                                                                                              J. BACTERIOL.


      TABLE 2. Bacterial strains plasmids used study
                                                                      Reference
  Strain plasmid                     Description
                                                                      source

E. coli
  DH5â?£                      Host cloning vectors                 GIBCO             FIG. 2. Diagram MVA operon inserted dxs. araC                                                                                      PBAD upstream yeast ERG genes, Kanr cassette S. typhimurium                                                                       located downstream.
   TR6579                   Host cloning vectors                 J. R. Roth
   TT22236                  LT2/pTP223                               J. R. Roth
   RMC25                    LT2 dxs::MVA operon                      work
   RMC26                    LT2 dxs::MVA operon                      work       homology regions flanking disruptions used sequencing.    RMC28                    RMC26/pTP223                             work       CAT insertions srlA srlB initially constructed TT22236.    CR4                      RMC26 ispD::Cam                          work       verification correct recombination event sequencing, srlA srlB
   TE3461                   Mud-cam source                           J. R. Roth      insertions crossed RMC26 standard P22 transduction, resulting    CR5                      RMC26 srlE::Cam                          work       strains RMC78 RMC79, respectively. primers used construct srlA
   CR24                     LT2 srlE::Cam                            work       insertion SsrlACam ASsrlBCam. Primers SsrlBCam ASsrlBCam
   CR29                     CR5 pBAD/srlE                            work       used srlB insertion. srlA insertion verified using primers
   RMC78                    RMC26 srlA::Cam                          work       SsrlAX ASsrlAX. analogous primers SsrlBX ASsrlBX used    RMC79                    RMC26 srlB::Cam                          work       sequence srlB insertion. Strains RMC26, CR5, RMC78, RMC79                                                                                      plated LB-KAN-MVA-Ara LB-KAN verify phenotype.
Plasmids                                                                                Partial purification ubiquinone Q8. Ubiquinone-8 (Q8) purified   pBAD/gIII                 Source araC PBAD                  Invitrogen      described Charon et al. (12) minor modifications. Mass spectrometry   pGEM-T Easy               TA cloning vector; Ampr                  Promega         performed using positive ion atmospheric pressure chemical ionization mass
  pGEM-T                    TA cloning vector; Ampr                  Promega         spectrometry (APCI) positive ion liquid secondary ion mass spectrometry
  pTP223                    â?­-Red genes                              J. R. Roth      (LSIMS). APCI performed direct injection sample dissolved   pFCO1                     ERG genes inserted                    20              1:4:1:1 chloroform-methanolâ€“n-butanolâ€“water. mobile phase 1:1 water-
                               pBluescript SKâ«¹                                       acetonitrile used flow rate 1 ml/min. LSIMS performed using
  pUC4K                     Contains Kanr cassette                   Pharmacia       m-nitrobenzyl alcohol matrix argon.
  pFCO1/kan                 pFCO1 Kanr cassettes                work
                               pUC4K
  pCAT53-3                  MVA operon                               work                                        RESULTS
  pRMC13                    Serovar Typhimurium dxs               work
                               pGEM-T                                                   Disruption chromosomal dxs S. enterica serovar Typhi-
  pRMC14                    Plasmid-encoded dxs::MVA                 work       murium. dxs mutant S. enterica serovar Typhimurium                                operon                                                constructed disruption gene synthetic operon
  pBAD/myc            Arabinose-induced expression             Invitrogen      containing genes Saccharomyces cerevisiae 
                               vector; Ampr
  pBAD/srlE                 srlE cloned pBAD/myc-               work       sponsible converting MVA IPP (20) control                                                                                PBAD promoter (10) (Fig. 2). pCAT53-3 constructed
                                                                                     plasmid pFCO1 adding Kanr cassette 3â¬˜ end
                                                                                     yeast ERG8 (phosphomevalonate kinase), ERG12 (MVA
                                                                                     kinase), ERG19 (MVA diphosphate decarboxylase) follows: initial denaturation 94Â°C 30 s, followed 20 cycles high-    adding araC gene PBAD promoter 5â¬˜ end. stringency PCR samples heated 94Â°C  hold time)          modified operon (MVAoperon) excised pCAT53-3 cooled 53Â°C  hold time), followed 1-min elongation step 72Â°C.      used disrupt plasmid-encoded dxs using CRC form
Thirty cycles low-stringency PCR ensued, samples heated 94Â°C  hold time) cooled 40Â°C  hold time), followed 1-min
                                                                                     pRMC14. traditional blunt-end ligation MVA
extension 72Â°C. Thirty additional cycles high-stringency PCR followed       operon dxs attempted successful. described                                                                      ligation likely failed size MVAoperon (â¬ƒ7
   Insertions identified semirandom PCR verified using standard          kb). stable integration S. enterica serovar Typhi-
primer PCR. mutants, MEP pathway genes probed insertions
                                                                                     murium chromosome generated â?­-Red-mediated ho-
using PCR.
   Construction directed knockouts srlE, srlA, srlB, ispD, ispE, ispF,     mologous recombination (23). Selection performed using
ispG RMC26. Disruptions srlE, srlA, srlB, MEP pathway genes           KAN resistance auxotrophy. Homologous 
ispD ispG constructed insertion CAT cassette using â?­-Red-       combination facilitated using pTP223, carries mediated linear recombination described disrupting dxs               phage â?­ genes encoding 5â¬˜-3â¬˜ exonuclease (exo) facilitate
MVAoperon. cases, insertion CAT cassette resulted partial gene deletion. primers designed PCR amplify CAT
                                                                                     interstrand invasion DNA (bet) host cell RecBCD-
cassette pACYC184 incorporating approximately 40 bp homology          inactivating protein (gam). construct synthesizes IPP target end amplificate. amplificate gel purified   MVA, supplemented Ara,  used directly transform recipient cells CAM resistance. srlE          Random mutagenesis RMC26. Mutagenesis  MEP pathway disruptions constructed RMC28 using primers
                                                                                     formed phage-mediated random â€œhoppingâ€? Mud-Cam
sgutEFRT2 asgutEFRT2, SygbPFRT2 ASygbPFRT2, sygbBcamPCR asygbBcamPCR, sychBcamPCR asychBcamPCR, sgcpEcam2                    element, contains CAT cassette, RMC26
asgcpEcam2 yield CR3 (srlE::Cam), CR2 (ispD::Cam), CT10 (ispE::Cam),              genome. Mutants exhibited desired phenotype CT11 (ispF::Cam), CR20 (ispG::Cam), respectively. correct inser-          growth MVA growth isolated, tion verified phenotype (growth MVA-Ara, growth , PCR             disrupted gene identified semirandom PCR using prim-
analysis, sequencing, disruptions backcrossed RMC26. primers SgutEseq ASgutEseq (srlE::Cam), sygbPseq asygbPseq
                                                                                     ers nested CAT cassette. total mutants exhib-
(ispD::Cam), sychBCamseq2 asychBCamseq2 (ispE::Cam), sygbBCamseq2                iting phenotype isolated, approximately asygbBCamseq2 (ispF::Cam), sgcpEseq asgcpEseq (ispG::Cam)                200,000 screened.
 VOL. 186, 2004                                          METHYL ERYTHRITOL TRANSPORT SEROVAR TYPHIMURIUM                           477


                                                                        analyzed positive-ion APCI positive-ion LSIMS.                                                                         APCI, peak m 727 observed corresponding M â«¹
                                                                        Hâ«¹ Q8 (MW â«½ 726). LSIMS spectrum peak                                                                         m 729, reflecting reduction quinone correspond-
                                                                        ing quinol mass spectral analysis, previously
                                                                        reported (12).
                                                                           Purified samples Q8 following incubations                                                                         analyzed LSIMS demonstrate utilization com-
                                                                        promised srlE disabled:   LT2 incubated LB;
   FIG. 3. Genetic evidence SrlE, SrlA, SrlB involved utilization exogenous  Growth patterns RMC26, CR5,         (ii) RMC26 incubated [1,1-2H2  (iii) RMC26 RMC78, RMC79 LB-KAN (left) LB-KAN-MVA-Ara                 incubated [1,1-2H2 MVA-Ara; (iv) CR5 (right) shown.                                                      incubated [1,1-2H2 MVA-Ara. LSIMS spec-
                                                                        tra shown Fig. 5. APCI spectra Q8 isolated                                                                         incubation ii peak m 743, LSIMS peak    Disruption srlE, srlA, srlB, MEP pathway genes (ispD          m 745, indicating complete incorporation deuterium ispG) RMC26 LT2. BLAST searches se-                   isoprenoid chain Q8. Incubation iii gave quences obtained semirandom PCR products                APCI peak 743 LSIMS peak 745, indicating mutants returned sequences srlE. gene                deuterium-labeled IPP incorporated exclusively encoding SrlE protein RMC28 disrupted homol-              Q8 chain. Q8 isolated incubation iv gave APCI
ogous recombination subsequently transduced                    peak 727 LSIMS peak 729, demonstrating RMC26 CR5. addition exhibiting phenotype              deuterium incorporation Q8 srlE disrupted. growth MVA-Ara growth  CR5 viable                   Characterization remaining insertion mutants. supplemented DX. Restoration growth DX                  isolated insertion mutations RMC26 mapped srlE.
supplementation indicated endogenous MEP pathway               remaining resistant semirandom PCR
remained intact suggested mechanism DX                 subsequent sequencing. remaining mu-
utilization different  srlE::CAT dis-           tants insertions known genes MEP pathway
ruption successfully crossed wild-type LT2.           probed primer PCR. Initial attempts complement
resulting strain, CR24, viable LB-CAM, indicating           mutations S. enterica serovar Typhimurium
srlE essential gene. srlA srlB genes        genomic library unsuccessful.
disrupted RMC26, resulting strains, RMC78 RMC79, exhibited phenotype growth MVA-Ara                                         DISCUSSION growth  Figure 3 displays growth patterns RMC26, CR5, RMC78, RMC79 plated                      Random mutagenesis RMC26 generated mutants
LB-KAN-MVA-Ara LB-KAN  strains                       desired phenotype disruptions srlE, viable medium supplemented MVA-                   encodes protein sorbitol PTS. PCR using genomic
Ara, RMC26 viable supplementation,                 DNA mutants template confirmed insertion indicating SrlA, SrlB, SrlE involved             srlE region. Insertion CAT cassette srlE produced
utilization. directed knockouts RMC26 MEP              MVA-Ara-dependent phenotype RMC26, confirming pathway genes resulted desired phenotype growth            involvement utilization. PTS-mediated phos-
MVA-Ara growth (unpublished results).                      phorylation, phosphate group PEP transferred    Q8 isolation analysis. Feeding experiments [1,1-            N1 position histidine residue EI subsequently
2
  H2 established SrlE required uptake uti-           transferred N1 position histidine HPr, lization cell. Q8 partially purified          steps sugar specific. phosphate following cultures: LT2 grown LB, RMC26 grown LB-                 transferred HPr histidine N3 EIIA KAN-[1,1-2H2  RMC26 grown LB-KAN-[1,1-2H2                      sugar-specific transport complex, followed transfer cys-
MVA-Ara, CR5 grown LB-CAM-[1,1-2H2 MVA-                       teine residue EIIB finally sugar molecule (45).
Ara. LT2 grown LB used control Q8 isolation.            coordinated mechanism EIIA, EIIB, Q8 derived unlabeled isoprene units molecular                EIIC subunits PTS  srlA srlB impli-
weight (MW) 726, Q8 derived [1,1-2H2                 cated srlE utilization. Insertions CAT MW 742 (Fig. 4). Q8 isolated LT2                  cassettes srlA srlB gave MVA-Ara-dependent phe-
                                                                        notype similar seen srlE, confirming role                                                                         genes utilization.
                                                                           Incorporation DX isoprenoids reported
                                                                        steps MEP pathway dis-
                                                                        covered (6, 19, 37, 40, 43). clear compounds
                                                                        phosphorylated utilized substrates
                                                                        MEP pathway. sorbitol PTS provides mechanism
                                                                        import phosphorylation  vitro experiments
 FIG. 4. Q8 derived MVA (left) [1,1-2H2 (right).       demonstrated D-xylulokinase (encoded xylB), MW.                                                                     enzyme responsible phosphorylating D-xylulose, phos-
 478     TESTA ET AL.                                                                                                     J. BACTERIOL.


                                                                    phorylates DX (46), transport mechanism                                                                     uptake cells reported. viability CR5
                                                                    DX present growth medium indicates                                                                     mechanism utilization DX MEP pathway                                                                     different  presumably identify
                                                                    gene  genes) responsible transporting exogenous
                                                                    DX performing similar set experiments described                                                                     work using DX instead screening
                                                                    process.
                                                                       Involvement srlE gene product utilization                                                                     exogenously supplied isoprenoid biosynthesis ver-
                                                                    ified biochemically analysis Q8. S. enterica serovar Ty-
                                                                    phimurium strain RMC26 readily incorporated deuterium
                                                                    label isoprenoid chain Q8. 
                                                                    ingly, RMC26, synthesizes isoprenoids                                                                     MVA, substantial preference utilization                                                                     incubated mixture MVA-Ara deuterium-
                                                                    labeled  contrast, incubation CR5, SrlE                                                                     sorbitol PTS disabled, mixture                                                                     substrates produced Q8 deuterium chain.
                                                                     functional copy SrlE protein required                                                                     utilization.
                                                                       sorbitol PTS complex appears responsible                                                                     phosphorylation  particular, SrlE protein                                                                     EIIB subunit sorbitol PTS analogous protein
                                                                    transfers phosphate sugar glucose PTS (18).
                                                                    D-sorbitol polyhydroxyl compounds,                                                                     absolute stereochemistries chiral centers pre-
                                                                    cisely map  clear operon
                                                                    responsible utilization sorbitol responsible                                                                     transport phosphorylation 
                                                                       cases overproduction enzymes MEP path-
                                                                    way stimulates synthesis isoprenoids (25, 26). exam-
                                                                    ple, higher levels lycopene obtained isopentenyl
                                                                    diphosphate isomerase overexpressed (25). level ly-
                                                                    copene increased DXP synthase MEP
                                                                    synthase overproduced (44). possible                                                                     stimulate synthesis lycopene overproduc-
                                                                    tion SrlA, SrlE, SrlB proteins DXP
                                                                    synthase MEP synthase.
                                                                       notable insertions seen known biosyn-
                                                                    thetic genes MEP pathway directed knock-
                                                                    outs genes RMC26 gave strains phe-
                                                                    notype CR5 (unpublished results). able                                                                     specifically disrupt MEP pathway genes                                                                     MEP synthase RMC26, exhibiting phenotype
                                                                    growth MVA-Ara growth                                                                      imply able identify mutations render
                                                                    genes inactive, isolated mutants
                                                                    appear involved uptake phosphorylation.                                                                     addition srlE mutants, unknown mutants                                                                     absolute requirement MVAoperon                                                                     readily lose recombination crossed                                                                     tightly linked marker, thiI::Tn10d-Tet. random
                                                                    insertions MEP pathway genes, MVA operon
                                                                    essential provide cellular isoprenoids, demon-
   FIG. 5. LSIMS spectra Q8 isolated feeding experiments:
  wild-type LT2 supplementation; (B) RMC26 supple-        strated inability CR4 lose MVA operon mented [1,1-2H2  (C) RMC26 supplemented [1,1-          cross. assumed 1,000 genes encoded
2
  H2 MVA-Ara; (D) CR5 supplemented [1,1-2H2 MVA-         S. enterica serovar Typhimurium chromosome, Ara.                                                                potential MEP pathway targets screen (ispD
 VOL. 186, 2004                                                    METHYL ERYTHRITOL TRANSPORT SEROVAR TYPHIMURIUM                                                479

 ispH) belonging proposed trans-                                Escherichia coli: fate 3-H 4-H atoms 1-deoxy-D-xylulose.
                                                                                          J. Chem. Soc. Chem. Commun. 17:1857â€“1858.
port (srlA, srlB, srlE, genes encoding HPr                       20.   Hahn, F. M., L. M. Eubanks, C.  Testa, B. S. Blagg, J.  Baker, C. D.
EI), estimated 100 mutants exhibiting phenotype                                 Poulter. 2001. 1-Deoxy-D-xylulose 5-phosphate synthase, gene product
growth MVA-Ara growth expected                                   open reading frame (ORF) 2816 ORF 2895 Rhodobacter capsula-
                                                                                          tus. J. Bacteriol. 183:1â€“11. completely random insertions. finding                          21.   Hecht, S., W. Eisenreich, P. Adam, S. Amslinger, K. Kis,  Bacher, D.
mutants 200,000 low. evidence explain                             Arigoni, F. Rohdich. 2001. Studies nonmevalonate pathway discrepancy.                                                                         terpenes: role GcpE (IspG) protein. Proc. Natl. Acad. Sci. USA
                                                                                          98:14837â€“14842.
                                                                                    22.   Herz, S., J. Wungsintaweekul, C.  Schuhr, S. Hecht, H. Lu  Â¨ttgen, S. Sagner,
                         ACKNOWLEDGMENTS                                                  M. Fellermeier, W. Eisenreich, M. H. Zenk,  Bacher, F. Rohdich. 2000.
                                                                                          Biosynthesis terpenoids: YgbB protein converts 4-diphosphocytidyl-2-C-
  thank John Roth helpful discussions, Lisa Eubanks pro-                       methyl-D-erythritol 2-phosphate 2-C-methyl-D-erythritol 2,4-cyclodiphos-
viding DXP synthase, David Fox MEP synthase.                                      phate. Proc. Natl. Acad. Sci. USA 97:2486â€“2490.
  R.M.C. NIH trainee supported grant GM 08537.                       23.   Hughes, K. T., J. R. Roth. 1988. Transitory cis complementation: project supported NIH grant GM 25521.                                              method providing transposition functions defective transposons. Ge-
                                                                                          netics 119:9â€“12.
                                                                                    24.   Jordan, P. M., P. N. Gibbs. 1983. Mechanism action beta-oxoacyl-
                                REFERENCES
                                                                                          CoA thiolase rat liver cytosol. Direct evidence order addition
 1. Agranoff, B. W., H. Eggerer, U. Henning, F. Lynen. 1959. Isopentenyl              acetyl-CoA molecules formation acetoacetyl-CoA.
    pyrophosphate isomerase. J.  Chem. Soc. 81:1254â€“1255.                              Biochem. J. 213:153â€“158.
 2. Altincicek, B., E. C. Duin,  Reichenberg, R. Hedderich,  K. Kollas, M.      25.   Kajiwara, S., P. D. Fraser, K. Kondo, N. Misawa. 1997. Expression     Hintz, S. Wagner, J. Wiesner, E. Beck, H. Jomaa. 2002. LytB protein               exogenous isopentenyl diphosphate isomerase gene enhances isoprenoid
    catalyzes terminal step 2-C-methyl-D-erythritol-4-phosphate path-          biosynthesis Escherichia coli. Biochem. J. 324:421â€“426.
    way isoprenoid biosynthesis. FEBS Lett. 532:437â€“440.                         26.   Kim, S.-W., J. D. Keasling. 2001. Metabolic engineering nonme-
 3. Altincicek, B.,  Kollas, M. Eberl, J. Wiesner, S. Sanderbrand, M. Hintz, E.         valonate isopentenyl diphosphate synthesis pathway Escherichia coli 
    Beck, H. Jomaa. 2001. LytB, novel gene 2-C-methyl-D-erythritol           hances lycopene production. Biotechnol. Bioeng. 72:408â€“415.
    4-phosphate pathway isoprenoid biosynthesis Escherichia coli. FEBS        27.   Koppisch,  T., D. T. Fox, B. S. Blagg, C. D. Poulter. 2002. E. coli MEP
    Lett. 499:37â€“40.                                                                      synthase: steady-state kinetic analysis substrate binding. Biochemistry
 4. Altincicek, B.,  K. Kollas, S. Sanderbrand, J. Wiesner, M. Hintz, E. Beck,          41:236â€“243.
    H. Jomaa. 2001. GcpE involved 2-C-methyl-D-erythritol 4-phos-     28.   Kuzuyama, T., M. Takagi, Kaneda, K., T. Dairi, H. Seto. 2000. Forma-
    phate pathway isoprenoid biosynthesis Escherichia coli. J. Bacteriol.           tion 4-(cytidine 5â¬˜-diphospho)-2-C-methyl-D-erythritol 2-C-methyl-
    183:2411â€“2416.                                                                        D-erythritol 4-phosphate 2-C-methyl-D-erythritol 4-phosphate cytidylyl-
 5. Amdur, B. H., H. Rilling, K. Bloch. 1957. enzymatic conversion             transferase. Tetrahedron Lett. 41:703â€“706.
    mevalonic acid squalene. J.  Chem. Soc. 79:2646â€“2647.                     29.   Kuzuyama, T., M. Takagi, K. Kaneda, H. Watanabe, T. Dairi, H. Seto.
 6. Arigoni, D., S. Sagner, C. Latzel, W. Eisenreich,  Bacher, M. H. Zenk.          2000. Studies nonmevalonate pathway: conversion 4-(cytidine 5â¬˜-
    1997. Terpenoid biosynthesis 1-deoxy-D-xylulose higher plants              diphospho)-2-C-methyl-D-erythritol 2-phospho derivative 4-(cyti-
    intramolecular skeletal rearrangement. Proc. Natl. Acad. Sci. USA                     dine 5â¬˜-diphospho)-2-C-methyl-D-erythritol kinase. Tetrahedron Lett. 41:
    94:10600â€“10605.                                                                       2925â€“2928.
 7. Blagg, B. S., C. D. Poulter. 1999. Synthesis 1-deoxy-D-xylulose      30.   Lange, B. M., M. R. Wildung, D. McCaskill, R. Croteau. 1998. family
    1-Deoxy-D-xylulose-5-phosphate. J. Org. Chem. 64:1508â€“1511.                           transketolases directs isoprenoid biosynthesis mevalonate-inde-
 8. Bloch, K., S. Chaykin,  H. Phillips,  Waard. 1959. Mevalonic acid          pendent pathway. Proc. Natl. Acad. Sci. USA 95:2100â€“2104.
    pyrophosphate isopentenyl pyrophosphate. J. Biol. Chem. 234:2595â€“           31.   LuÂ¨ttgen, H., F. Rohdich, S. Herz, J. Wungsintaweekul, S. Hecht, C. 
    2604.                                                                                 Schuhr, M. Fellermeier, S. Sagner, M. H. Zenk,  Bacher, W. Eisen-
 9. Bochar, D. , J.  Freisen, C. V. Stauffacher, V. W. Rodwell. 1999.             reich. 2000. Biosynthesis terpenoids: YchB protein Escherichia coli
    Biosynthesis mevalonic acid acetyl-CoA, p. 15â€“44. D. Cane (ed.),           phosphorylates 2-hydroxy group 4-diphosphocytidyl-2-C-methyl-D-
    Comprehensive natural products chemistry, vol. 2. Pergamon Press, Oxford,             erythritol. Proc. Natl. Acad. Sci. USA 97:1062â€“1067.
    United Kingdom.
                                                                                    32.   McAteer, S.,  Coulson, N. McLennan, M. Masters. 2001. lytB gene
10. Campos, N., M. Rodriguez-Concepcion, S. Sauret-Gueto, F. Gallego, L. M.
                                                                                          Escherichia coli essential specifies product needed isoprenoid
    Lois,  Boronat. 2001. Escherichia coli engineered synthesize iso-
                                                                                          biosynthesis. J. Bacteriol. 183:7403â€“7407.
    pentenyl diphosphate dimethylallyl diphosphate mevalonate:                                                                                     33.   Miziorko, H. M., M. D. Lane. 1977. 3-Hydroxy-3-methylgutaryl-CoA
    novel genetic analysis 2-C-methyl-D-erythritol 4-phos-
                                                                                          synthase. Participation acetyl-S-enzyme enzyme-S-hydroxymethylgu-
    phate pathway isoprenoid biosynthesis. Biochem. J. 353:59â€“67.
                                                                                          taryl-SCoA intermediates reaction. J. Biol. Chem. 252:1414â€“1420.
11. Campos, N., M. Rodriguez-Concepcion, M. Seemann, M. Rohmer, 
    Boronat. 2001. Identification gcpE novel gene 2-C-methyl-D-      34.   Pachuk, C. J., M. Samuel, J.  Zurawski, L. Snyder, P. Phillips, C.
    erythritol 4-phosphate pathway isoprenoid biosynthesis Escherichia             Satishchandran. 2000. Chain reaction cloning: step method direc-
    coli. FEBS Lett. 488:170â€“173.                                                         tional ligation multiple DNA fragments. Gene 243:19â€“25.
12. Charon, L., J. F. Hoeffler, C. Pale-Grosdemange, L. M. Lois, N. Campos,       35.   Poteete,  R.,  C. Fenton. 2000. Genetic requirements phage
    Boronat, M. Rohmer. 2000. Deuterium-labelled isotopomers 2-C-                  lambda red-mediated gene replacement Escherichia coli K-12. J. Bacteriol.
    methyl-D-erythritol tools elucidation 2-C-methyl-D-eryth-           182:2336â€“2340.
    ritol 4-phosphate pathway isoprenoid biosynthesis. Biochem J. 346:737â€“      36.   Price-Carter, M., J. Tingey, T.  Bobik, J. R. Roth. 2001. alterna-
    742.                                                                                  tive electron acceptor tetrathionate supports B12-dependent anaerobic
13. Cunningham, F. X., Jr., T. P. Lafond, E. Gantt. 2000. Evidence role          growth Salmonella enterica serovar Typhimurium ethanolamine     LytB nonmevalonate pathway isoprenoid biosynthesis. J. Bac-             1,2-propanediol. J. Bacteriol. 183:2463â€“2475.
    teriol. 182:5841â€“5848.                                                          37.   Putra, S. R., L. M. Lois, N. Campos,  Boronat, M. Rohmer. 1998.
14. Davis, R. W., D. Bolstein, J. R. Roth. 1980. Advanced bacterial genetics.         Incorporation [2,3â€“13C2]- [2, 4â€“13C2]-D-1-deoxyxylulose ubiqui-
    Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.                          Escherichia coli mevalonate-independent pathway iso-
15. Dhe-Paganon, S., J. Magrath, R. H. Abeles. 1994. Mechanism meva-               prenoid biosynthesis. Tetrahedron Lett. 39:23â€“26.
    lonate pyrophosphate decarboxylase: evidence carbocationic transition     38.   Rohdich, F., S. Hecht, K. Gartner, P. Adam, C. Krieger, S. Amslinger, D.
    state. Biochemistry 33:13355â€“13362.                                                   Arigoni,  Bacher, W. Eisenreich. 2002. Studies nonmevalonate
16. Duvold, T., P. Cali, J.-M. Bravo, C. Pale-Grosdemange, M. Rohmer.                 terpene biosynthetic pathway: metabolic role IspH (LytB) protein. Proc.
    1997. Incorporation 2-C-methyl-D-erythritol, putative isoprenoid inter-          Natl. Acad. Sci. USA 99:1158â€“1163.
    mediate mevalonate-independent pathway, ubiquinone              39.   Rohdich, F., J. Wungsintaweekul, M. Fellermeier, S. Sagner, S. Herz, K. Kis,
    menaquinone Escherichia coli. Tetrahedron Lett. 38:4769â€“4772.                      W. Eisenreich,  Bacher, M. H. Zenk. 1999. Cytidine 5â¬˜-triphosphate-
17. Elliot, T. 1993. Transport 5-aminolevulinic acid dipeptide permease         dependent biosynthesis isoprenoids: YgbP protein Escherichia coli
    Salmonella typhimurium. J. Bacteriol. 175:325â€“331.                                 catalyzes formation 4-diphosphocytidyl-2-C-methylerythritol. Proc.
18. Erni, B., H. Trachsel, P. W. Postma, J. P. Rosenbusch. 1982. Bacterial            Natl. Acad. Sci. USA 96:11758â€“11763.
    phosphotransferase  Solubilization purification glucose-      40.   Sagner, S., C. Latzel, W. Eisenreich,  Bacher, M. H. Zenk. 1998. Dif-
    specific enzyme II membranes Salmonella typhimurium. J. Biol.                 ferential incorporation 1-deoxy-D-xylulose monoterpenes caro-
    Chem. 257:13726â€“13730.                                                                tenoids higher plants. J. Chem. Soc. Chem. Commun. 2:221â€“222.
19. Giner, J. L., B. Jaun, D. Arigoni. 1998. Biosynthesis isoprenoids     41.   Sambrook, J., E. F. Fritsch, T. Maniatis. 1989. Molecular cloning:  480      TESTA ET AL.                                                                                                                         J. BACTERIOL.

    laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring            mevalonate isopentenyl diphosphate pathway Escherichia coli enhances
    Harbor, N.Y.                                                                     lycopene production. Biotechnol. Bioeng. 72:408â€“415.
42. Schmieger, H. 1972. Phage P22 mutants increased decreased trans-     45. Tchieu, J. H., V. Norris, J. S. Edwards, M. H. Saier, Jr. 2001.     duction abilities. Mol. Gen. Genet. 119:75â€“88.                                   complete phosphotranferase Escherichia coli. J. Mol. Microbiol.
43. Schwender, J., J. Zeidler, R. Groner, C. Muller, M. Focke, S. Braun, F. W.